Evidence map›Paper›PMID 33778721›Full record

ReviewRadiology. Imaging cancer2020

Precision Digital Oncology: Emerging Role of Radiomics-based Biomarkers and Artificial Intelligence for Advanced Imaging and Characterization of Brain Tumors.

Reza Forghani

Open access · diamondAbstract readReview
In one paragraph

Review in Radiology. Imaging cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Reza ForghaniDepartment of Radiology, McGill University Health Centre, 1001 Decarie Blvd, Room C02.5821, Montreal, QC, Canada H4A 3J1; Augmented Intelligence & Precision Health Laboratory (AIPHL), Research Institute of the McGill University Health Centre, Montreal, Canada; Segal Cancer Centre and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada; and Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Canada.ORCID 0000-0002-8572-1864
McGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in computerized image analysis and the use of artificial intelligence-based approaches for image-based analysis and construction of prediction algorithms represent a new era for noninvasive biomarker discovery. In recent literature, it has become apparent that radiologic images can serve as mineable databases that contain large amounts of quantitative features with potential clinical significance. Extraction and analysis of these quantitative features is commonly referred to as texture or radiomic analysis. Numerous studies have demonstrated applications for texture and radiomic characterization methods for assessing brain tumors to improve noninvasive predictions of tumor histologic characteristics, molecular profile, distinction of treatment-related changes, and prediction of patient survival. In this review, the current use and future potential of texture or radiomic-based approaches with machine learning for brain tumor image analysis and prediction algorithm construction will be discussed. This technology has the potential to advance the value of diagnostic imaging by extracting currently unused information on medical scans that enables more precise, personalized therapy; however, significant barriers must be overcome if this technology is to be successfully implemented on a wide scale for routine use in the clinical setting.

Indexed as

Artificial IntelligenceBrain NeoplasmsBiomarkers, TumorDiagnostic ImagingHumansImage Processing, Computer-AssistedBiomarkers, Tumor

Identifiers

PMID33778721
PMCPMC7983689
OpenAlexW3046599714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.